Research News

Researchers at the Jacobs School of Medicine and Biomedical Sciences are attempting to prevent those with prediabetes from developing Type 2 diabetes.

Tracey A. Ignatowski, PhD, assistant professor of pathology and anatomical sciences, has developed a treatment for chronic pain that could have an impact in dealing with the opioid crisis.

University at Buffalo researchers have launched a study that combines artificial intelligence (AI) with data gathered by continuous glucose monitoring devices.

David Dietz, PhD, associate professor and chair of pharmacology and toxicology, is senior author on a pair of papers dealing with the study of drug relapse.

The nation’s first Opioid Intervention Court (OIC) was established in Buffalo in 2017 after — in a single week — three traditional drug-treatment court defendants fatally overdosed on opioids before their second court appearance.

The difficulty of reversing obesity in adults is well known and the deleterious effects that obesity has on an individual’s health can range from diabetes to heart disease to cancer.

Bruce R. Troen, MD, professor of medicine and chief of the Division of Geriatrics and Palliative Medicine, received a rare, perfect score from the National Institutes of Health (NIH) on his grant application for expansion of a center designed to enhance care for older adults throughout Western New York.

Pinaki Sarder, PhD, assistant professor of pathology and anatomical sciences, and doctoral student Brandon Ginley have developed a new method that automates the classification of progressive diabetic kidney disease, reducing variability and boosting precision.

The University at Buffalo has officially launched the UB Biorepository, a critical new facility in the Clinical and Translational Research Center that will serve as a powerful resource in driving biomedical innovation in academia and industry regionally and throughout the state.